BSEBoard Meeting2d ago · 28 Oct 2026, 02:45 pm

Ishita Drugs & Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve 1. To consider, approve and take on record the Unaudited Financial Results of the Company for the quarter ended 30th September, 2026. 2. Any other matter with permission of the Chair.

Ishita Drugs & Industries Ltd · 524400

✦ AI SummaryResults

Ishita Drugs & Industries Ltd has scheduled a Board Meeting on 03/11/2026 to consider and approve the Unaudited Financial Results for the quarter ended 30th September, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Ishita Drugs & Industries Ltd - 524400 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) Regulations, 2015 For The Quarter Ended 30Th September, 2026

Attachments (1)

📄

46fb0b47-abb2-47ea-a80b-19c952345f4f.pdf

pdf

Download →
View document text
ISHITA DRUGS & INDUSTRIES LTD. Corp. Offts 401, 3rd Eye 11, Opp. Parlmal Garden, C. G. Road, Ahmedabad-380006. RRngd. Office & Factory : 179/I, \fasna-Iya`ra. Tat. Sanand. Dist. : Ahmedabad. E-mall : ishitadnJzs@rmall.com I lnfo@lshitadrufs.com I URL : www.ishitadruE!s.com Phone : +91 7226995613/ 14/ 15 +91 79 4002 3839 Date: 28.10.2026 The Department of Corporate.Services, The BSE Limited Floor No. 25, Phiroze )eejeebhoy Towers, Dalal Street, Mumbai -400 001. ScriD Code: 524400 ` Dear sir/Madam, Oblifratious and Disclosure Reauirementsl Renllatjous. 2015 for the quarter ended 30th September. 2026 Notice is hereby given that pursuant to Regulation 29 (Listing Obligations and Disclosure RRequirements) Regulations, 2015, that the meeting of the Board of Directors of the Company will be held on Tuesday, 03rd November, 2026 to transact the following business: 1. To consider, approve and take on record the Unaudited Financial Results of the Company for the quarter ended 30th September, 2026. 2. Any other matter with permission of the chair. Further in accordance with Code of Conduct for Prevention of Insider Trading Framed by the Company pursuant to the SEBI tt'rohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company by Designated Persons of the Company (`Code|, stands closed from Thursday, 01'st October, 2026 till 48 hours from the announcement of the Unaudited Financial Results for the quarter ended 30th September, 2026. Kindly take the above on your records. Thanking You, For, Ishita Drugs and Industries Limited 7agdish Agrawal Managing Director DIN: 01031687 `our6asiedyinthesatri;elfhrmoni:6=oorawide" CIN No. L24231GJ1992PLC017054 D a a D-U-NS Number -65J)18ro359